Stockscreener 앱 받기
218.80
0.03%
-0.07
전일 마감가:
$218.87
열려 있는:
$219.62
하루 거래량:
646.12K
Relative Volume:
0.81
시가총액:
$16.36B
수익:
$2.90B
순이익/손실:
$467.20M
주가수익비율:
34.35
EPS:
6.37
순현금흐름:
$306.90M
1주 성능:
+0.97%
1개월 성능:
+3.77%
6개월 성능:
-33.20%
1년 성능:
-33.57%
1일 변동 폭
$216.30
$221.74
1주일 범위
$215.66
$223.77
52주 변동 폭
$187.43
$352.33
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
218.80 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
|
ISRG
Intuitive Surgical Inc
|
543.41 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
172.25 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.28 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
258.00 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
KeyBanc reiterates West Pharmaceutical stock rating on GLP-1 growth - Investing.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming DeadlinesWST - FinancialContent
Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline - ACCESS Newswire
KeyBanc reiterates West Pharmaceutical stock rating on GLP-1 growth By Investing.com - Investing.com UK
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - FinancialContent
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - StreetInsider
Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)Levi & Korsinsky Reminds Investors of July 7, 2025 - ACCESS Newswire
Is West Pharmaceutical Services Stock Underperforming The Nasdaq? - Barchart.com
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc.(WST) Shareholders - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm - Morningstar
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
2025-06-16 | Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action | NYSE:WST | Press Release - Stockhouse
Deadline Alert: West Pharmaceutical Services, Inc. (WST) - GlobeNewswire
Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - TradingView
West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline - ACCESS Newswire
The Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025WST - PR Newswire
Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class ActionContact Levi & Korsinsky - ACCESS Newswire
WST Deadline: WST Investors with Losses in Excess of $100K Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit - Morningstar
Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025Contact Levi & Korsinsky - ACCESS Newswire
WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, - GlobeNewswire
WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, ... - Eagle-Tribune
WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – WST - TradingView
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action - ACCESS Newswire
West Pharmaceutical Services, Inc. Sued for Securities Law - GlobeNewswire
Investors in West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your RightsWST - Kilgore News Herald
Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST)Contact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
Should You Hold West Pharmaceutical Services (WST)? - Insider Monkey
July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST)Contact Levi & Korsinsky - ACCESS Newswire
WST INVESTOR ALERT: Kirby McInerney LLP Notifies West - GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates - GlobeNewswire
WST Lead Plaintiff Deadline Approaching – WST Stockholders Should Contact Robbins LLP for Information About Leading the West Pharmaceutical Services, Inc. Class Action Lawsuit - GlobeNewswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
West Pharmaceutical Services, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before July 7, 2025 to Discuss Your RightsWST - marketscreener.com
Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) – Contact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors ... - Eagle-Tribune
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages West - GlobeNewswire
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST - TradingView
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PrimePublishers.com
Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST)Contact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit - Morningstar
July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST)Contact Levi & Korsinsky - ACCESS Newswire
Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST) - ACCESS Newswire
Investors in West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July ... - Bluefield Daily Telegraph
Investors in West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights – WST - TradingView
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. LawsuitWST - GuruFocus
Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors – Contact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - marketscreener.com
Wall Street Analysts Believe West Pharmaceutical (WST) Could Rally 26.92%: Here's is How to Trade - Yahoo Finance
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
West Pharmaceutical Services Inc 주식 (WST) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Reiss-Clark Cindy | Chief Commercial Officer |
Feb 18 '25 |
Option Exercise |
211.00 |
246 |
51,940 |
5,131 |
| MacKay Kimberly Banks | SVP, GC & Corporate Secretary |
Feb 18 '25 |
Option Exercise |
211.00 |
246 |
51,940 |
1,605 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Feb 18 '25 |
Option Exercise |
211.00 |
246 |
51,940 |
6,823 |
| Winters Chad | VP, Chief Accounting Officer |
Feb 18 '25 |
Option Exercise |
211.00 |
82 |
17,313 |
1,391 |
| Witherspoon Charles | VP & Treasurer |
Feb 18 '25 |
Option Exercise |
211.00 |
66 |
13,864 |
1,319 |
| Green Eric Mark | President, CEO and Board Chair |
Feb 18 '25 |
Option Exercise |
211.00 |
2,461 |
519,269 |
170,369 |
| Witherspoon Charles | VP & Treasurer |
Oct 29 '24 |
Option Exercise |
173.22 |
478 |
82,799 |
1,956 |
| Witherspoon Charles | VP & Treasurer |
Oct 29 '24 |
Sale |
310.40 |
703 |
218,211 |
1,253 |
| Abraham Silji | SVP, Chief Technology Officer |
Oct 29 '24 |
Option Exercise |
0.00 |
458 |
0 |
3,318 |
| Witherspoon Charles | VP & Treasurer |
Aug 19 '24 |
Option Exercise |
102.51 |
529 |
54,228 |
2,507 |
0.36%
0.23%
자본화:
|
볼륨(24시간):